Craif Inc, a Japanese molecular diagnostics company focused on early cancer detection, has announced raising $22 million in a Series C funding round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
